BIIB Jan 2025 290.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:00PM EDT. Market open.
| Previous close | 2.7500 |
| Open | 2.8000 |
| Bid | 2.2000 |
| Ask | 2.6500 |
| Strike | 290.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.7500 - 2.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 67 |
Investor's Business DailyBiogen Stock Surges After Two Notable Products Walloped Sales Expectations
Two of Biogen's newest drugs walloped first-quarter sales expectations on Wednesday, and helped Biogen stock jump.
ZacksBiogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Biogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key drugs like Tecfidera, Tysabri & Spinraza declined, the company's cost-saving efforts show promise.
© 2024 Yahoo. All rights reserved.